Moderna’s new COVID-19 vaccine mNexspike approved by FDA, but there’s a limit on who can use it
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, which is a lower-dose option targeting high-risk individuals aged 65 and ...
Wednesday, August 6, 2025
Tag: COVID-19 Vaccine
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.